No Tribal Immunity in PTO Proceedings, Federal Circuit Rules


So ruled the U.S. Court of Appeals for the Federal Circuit on July 20, bringing to an end-absent Supreme Court review-a controversy that has roiled the patent world for much of the last year. A unanimous panel affirmed a Patent Trial and Appeal Board decision to proceed with inter partes review proceedings of Allergan Inc.'s patents on a dry eye treatment.



from Biotech News